Literature DB >> 890205

Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.

A R Green, B D Mitchell, A F Tordoff, M B Youdim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 890205      PMCID： PMC1667291          DOI： 10.1111/j.1476-5381.1977.tb07506.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  12 in total

Review 1.  Multiple forms of monoamine oxidase: fact and artefact.

Authors:  M D Houslay; K F Tipton
Journal:  Life Sci       Date:  1976-08-15       Impact factor: 5.037

2.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Human brain monoamine oxidase: multiple forms and selective inhibitors.

Authors:  M B Youdim; G G Collins; M Sandler; A B Bevan Jones; C M Pare; W J Nicholson
Journal:  Nature       Date:  1972-03-31       Impact factor: 49.962

5.  The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.

Authors:  A R Green; D G Grahame-Smith
Journal:  Neuropharmacology       Date:  1974-11       Impact factor: 5.250

6.  The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.

Authors:  H Y Yang; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1974-06       Impact factor: 4.030

7.  Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain.

Authors:  G Curzon; A R Green
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

8.  Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.

Authors:  A R Green; M B Youdim
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

9.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

10.  Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.

Authors:  A R Green; P H Kelly
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739
View more
  35 in total

Review 1.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex.

Authors:  J Semba; M Doheny; P N Patsalos; G Sarna; G Curzon
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 3.  On the practical aspects of characterising monoamine oxidase inhibition in vitro.

Authors:  Andrew Holt
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

4.  Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.

Authors:  M B Youdim; A Gross; J P Finberg
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.

Authors:  Zelan Wei; Tamara Satram-Maharaj; Bradley Chaharyn; Kelly Kuski; Paul R Pennington; Xia Cao; Jennifer Chlan; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2012-03-03       Impact factor: 3.575

6.  The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.

Authors:  Yotam Sagi; Noam Driguès; Moussa B H Youdim
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

7.  5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.

Authors:  A Adell; R D Myers
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

8.  Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

Authors:  Z Speiser; T Fine; L Litinetsky; S Eliash; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2007-09-07       Impact factor: 3.575

9.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

10.  Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study.

Authors:  N B Mercuri; A Bonci; A Siniscalchi; A Stefani; P Calabresi; G Bernardi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.